MENU
LTRN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lantern Pharma (LTRN) Ownership - Who owns Lantern Pharma?
Profile
Industry
N/A
Address
1920 McKinney Avenue
Phone
+1 972 277-1136
Employees
21
Web
https://www.lanternpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
33.76M
P/E Ratio
N/A
Total Cash
28.05M
Projected Growth
N/A
Total Debt
291.24K
Revenue
N/A
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash/Share
2.60
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
LTRN
Capitalization
33.8M
P/E Ratio
N/A
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash
28.1M
Total Cash/Share
2.60
Total Debt
291K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
26.6M
P/B Ratio
1.28
Cash Flow
N/A
Earnings
-1.78
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.08K
Current Ratio
8.31
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-21.18M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-48.91
Shares Held By Institutions
6.54M
Shares Outstanding - Current
10.8M
Total Liabilities
3.7M
Total Volume MTD
N/A
Value
1
Gain YTD
-26.519
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1920 McKinney Avenue
Phone
+1 972 277-1136
Employees
21
Web
https://www.lanternpharma.com